Acumen Pharmaceuticals (ABOS) Stock: Buy, Sell, or Hold?
ABOS - Acumen Pharmaceuticals, Inc. Common Stock
$0.22
0.01 (4.54%)
▲
5d:
+6.38%
30d:
-89.36%
90d:
-90.8%
HOLD
MODERATE Confidence
Analysis Updated: Nov 6, 2026 12:00 AM ET
Earnings: Oct 26, 2026
0d
Get Alerted When ABOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABOS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABOS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABOS is currently trading at $0.22, which is considered oversold relative to its 30-day fair value range of $0.94 to $2.44.
Technical Outlook: Technically, ABOS is in a downtrend. Immediate support is located at $0.19, while resistance sits at $2.52. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+347.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABOS is in a downtrend. Immediate support is located at $0.19, while resistance sits at $2.52. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+347.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.94 -
$2.44
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Strong upward momentum (+4.5%)
- BULLISH: Trading 347.4% below Wall St target ($1.00)
- NEUTRAL: Bottoming setup forming (55/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$0.94 -
$2.44
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.19
Resistance Level
$2.52
Current Trend
Downtrend
Technical data as of
Nov 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.46
Wall Street Target
$1.00
(+347.4%)
Share ABOS Analysis
Share this live ABOS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ABOS)
Bullish
6 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
5 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Acumen Pharmaceuticals is preparing to report top-line results from its Phase II trial of sabirnetug, a monoclonal antibody designed to neutralize toxic amyloid-beta oligomers in Alzheimer's patients, in November 2026. Positive results could validate the company's approach and pave the way for a single confirmatory Phase III trial.
Key Retail Themes:
Upcoming Phase II trial results
Regulatory approval potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 09, 2026 3:41 AM ET
Data refreshes hourly during market hours. Next update: 4:41 AM
Data refreshes hourly during market hours. Next update: 4:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 47 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 42 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 63 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 43 HOLD |
|
EPRX
Eupraxia Pharmaceuticals… |
STRONG BUY
12 analysts |
$17 | 64 BUY |
More Analysis for ABOS
ABOS Technical Chart
ABOS Price Prediction
ABOS Earnings Date
ABOS Investment Advisor
ABOS Fair Price Analyzer
ABOS Competitors
ABOS DCF Intrinsic Value
Stock Sector Rotation Tracker
AI & Semi Supply Chain Money Flow
Live Gamma Exposure (GEX) Scanner
Reddit & WSB Sentiment Tracker
Backtested Stock Scanner
